retatrutide clinical trial results 2024 2025 press release Lilly's triple G agonist boasts 28.7% weight loss in Phase III Incretin-based therapies for the treatment
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25


























